lithium(1+) ion

• ChemBase ID: 1184
• Molecular Formular: Li+
• Molecular Mass: 6.941
• Monoisotopic Mass: 7.01600455
• SMILES: [Li+]
• Canonical SMILES: [Li+]
• InChI: InChI=1S/Li/q+1
• InChIKey: HBBGRARXTFLTSG-UHFFFAOYSA-N

NAMES AND DATABASE IDS

Names

• IUPAC name: lithium(1+) ion
• IUPAC Traditional name: LithoTab
• Brand Name: LithoTab; Eskalith
• Synonyms: Lithium

Database IDs

• CAS Number: 7439-93-2
• PubChem SID: 46505392; 160964646
• PubChem CID: 28486

CALCULATED PROPERTIES

• H Acceptors: 0
• H Donor: 0
• LogD (pH = 5.5): 0.0
• LogD (pH = 7.4): 0.0
• Log P: 0.0
• Molar Refractivity: 0.0 cm^3
• Polarizability: 1.7969184 Å^3
• Polar Surface Area: 0.0 Å^2
• Rotatable Bonds: 0
• Lipinski's Rule of Five: true

DETAILS

DrugBank - DB01356

• Drug Groups: approved
• Description: Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.
• Indication: Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment.
• Pharmacology: Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors.
• References: Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK: Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology. 2010;62(1):50-60. Epub 2010 May 7. [Pubmed]
• External Links: Wikipedia; RxList; Drugs.com

REFERENCES

• Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK: Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology. 2010;62(1):50-60. Epub 2010 May 7. Pubmed